 |
市场调查报告书
商品编码
1411690
去氨加压素市场：型态、销售管道和最终用户划分 - 全球预测 2024-2030Desmopressin Market by Form (Injectable Solution, Nasal Spray, Tablet), Sales Channel (Offline, Online), End-Users - Global Forecast 2024-2030 |
||||||
价格
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年去氨加压素市场规模为12.5亿美元，预计2024年将达13亿美元，2030年将达到19.7亿美元，复合年增长率为6.68%。
去氨加压素全球市场
| 主要市场统计 | |
|---|---|
| 基准年[2023] | 12.5亿美元 |
| 预测年份 [2024] | 13亿美元 |
| 预测年份 [2030] | 19.7亿美元 |
| 复合年增长率（%） | 6.68% |
FPNV定位矩阵
FPNV定位矩阵对于评估去氨加压素市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。
市场占有率分析
市场占有率分析是一种综合工具，可以对去氨加压素市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略，从而在市场上获得竞争优势。
该报告对以下几个方面提供了宝贵的见解：
1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。
2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。
3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4-竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。
本报告解决了以下关键问题：
1-去氨加压素市场的市场规模和预测是多少？
2-去氨加压素市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？
3-去氨加压素市场的技术趋势和法律规范是什么？
4-去氨加压素市场主要供应商的市场占有率是多少？
5-进入去氨加压素市场的合适型态和策略手段是什么？
目录
第一章 前言
第二章调查方法
第三章执行摘要
第四章市场概况
第五章市场洞察
- 市场动态
- 促进因素
- 全球尿崩症患者发生率增加
- 支持糖尿病意识和治疗的政府措施和计划
- 抑制因素
- 与去氨加压素相关的不良反应
- 机会
- 新配方的持续研发活动
- 去氨加压素的监管核准增加
- 任务
- 替代药物的可得性
- 促进因素
- 市场区隔分析
- 市场趋势分析
- 高通膨的累积效应
- 波特五力分析
- 价值炼和关键路径分析
- 法律规范
第六章 去氨加压素市场：依型态
- 注射液
- 滴鼻剂
- 药片
第七章去氨加压素市场：依销售管道
- 离线
- 在线的
第 8 章 去氨加压素市场：依最终用户分类
- 居家护理
- 医院
- 专科诊所
第9章 美洲去氨加压素市场
- 阿根廷
- 巴西
- 加拿大
- 墨西哥
- 美国
第10章 亚太地区去氨加压素市场
- 澳洲
- 中国
- 印度
- 印尼
- 日本
- 马来西亚
- 菲律宾
- 新加坡
- 韩国
- 台湾
- 泰国
- 越南
第十一章 欧洲、中东和非洲去氨加压素市场
- 丹麦
- 埃及
- 芬兰
- 法国
- 德国
- 以色列
- 义大利
- 荷兰
- 奈及利亚
- 挪威
- 波兰
- 卡达
- 俄罗斯
- 沙乌地阿拉伯
- 南非
- 西班牙
- 瑞典
- 瑞士
- 土耳其
- 阿拉伯聯合大公国
- 英国
第十二章竞争形势
- FPNV定位矩阵
- 市场占有率分析：主要企业
- 主要企业竞争情境分析
第13章竞争产品组合
- 主要公司简介
- AA Pharma Inc.
- Amring Pharmaceuticals Inc.
- Antares Pharma, Inc. by Halozyme, Inc.
- Apotex Inc.
- Avadel Pharmaceuticals PLC
- Bachem AG
- BluePoint Laboratories
- CSC Pharmaceuticals International
- Dr. Reddy's Laboratories Ltd.
- Enomark
- Ferring Pharmaceuticals
- Glenmark Pharmaceuticals Limited
- Horizon NJ Health by Horizon Blue Cross Blue Shield of New Jersey
- KVR Pharmaceuticals
- Manus Aktteva Biopharma LLP
- Midas Pharma GmbH
- NorthStar Rx LLC
- Pfizer Inc.
- Ralington Pharma LLP
- Saintroy Lifescience
- Sanofi SA
- Sava Healthcare Limited
- Sun Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries Ltd.
- VIVAN Life Sciences Pvt. Limited
- 主要产品系列
第十四章附录
- 讨论指南
- 关于许可证和定价
Product Code: MRR-C002B1C994B9
[194 Pages Report] The Desmopressin Market size was estimated at USD 1.25 billion in 2023 and expected to reach USD 1.30 billion in 2024, at a CAGR 6.68% to reach USD 1.97 billion by 2030.
Global Desmopressin Market
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 1.25 billion |
| Estimated Year [2024] | USD 1.30 billion |
| Forecast Year [2030] | USD 1.97 billion |
| CAGR (%) | 6.68% |
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Desmopressin Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Desmopressin Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Desmopressin Market, highlighting leading vendors and their innovative profiles. These include AA Pharma Inc., Amring Pharmaceuticals Inc., Antares Pharma, Inc. by Halozyme, Inc., Apotex Inc., Avadel Pharmaceuticals PLC, Bachem AG, BluePoint Laboratories, CSC Pharmaceuticals International, Dr. Reddy's Laboratories Ltd., Enomark, Ferring Pharmaceuticals, Glenmark Pharmaceuticals Limited, Horizon NJ Health by Horizon Blue Cross Blue Shield of New Jersey, KVR Pharmaceuticals, Manus Aktteva Biopharma LLP, Midas Pharma GmbH, NorthStar Rx LLC, Pfizer Inc., Ralington Pharma LLP, Saintroy Lifescience, Sanofi S.A., Sava Healthcare Limited, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., and VIVAN Life Sciences Pvt. Limited.
Market Segmentation & Coverage
This research report categorizes the Desmopressin Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Form
- Injectable Solution
- Nasal Spray
- Tablet
- Sales Channel
- Offline
- Online
- End-Users
- Homecare
- Hospitals
- Specialty Clinics
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Desmopressin Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Desmopressin Market?
3. What are the technology trends and regulatory frameworks in the Desmopressin Market?
4. What is the market share of the leading vendors in the Desmopressin Market?
5. Which modes and strategic moves are suitable for entering the Desmopressin Market?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
- 4.1. Introduction
- 4.2. Desmopressin Market, by Region
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising occurrence of diabetes insipidus in patients worldwide
- 5.1.1.2. Government initiatives and programs supporting diabetes awareness & treatment
- 5.1.2. Restraints
- 5.1.2.1. Adverse effects associated with the desmopressin
- 5.1.3. Opportunities
- 5.1.3.1. Ongoing research & development activities for new formulations
- 5.1.3.2. Increasing in regulatory approvals for desmopressin
- 5.1.4. Challenges
- 5.1.4.1. Availability of alternative medicines
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
6. Desmopressin Market, by Form
- 6.1. Introduction
- 6.2. Injectable Solution
- 6.3. Nasal Spray
- 6.4. Tablet
7. Desmopressin Market, by Sales Channel
- 7.1. Introduction
- 7.2. Offline
- 7.3. Online
8. Desmopressin Market, by End-Users
- 8.1. Introduction
- 8.2. Homecare
- 8.3. Hospitals
- 8.4. Specialty Clinics
9. Americas Desmopressin Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific Desmopressin Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa Desmopressin Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. AA Pharma Inc.
- 13.1.2. Amring Pharmaceuticals Inc.
- 13.1.3. Antares Pharma, Inc. by Halozyme, Inc.
- 13.1.4. Apotex Inc.
- 13.1.5. Avadel Pharmaceuticals PLC
- 13.1.6. Bachem AG
- 13.1.7. BluePoint Laboratories
- 13.1.8. CSC Pharmaceuticals International
- 13.1.9. Dr. Reddy's Laboratories Ltd.
- 13.1.10. Enomark
- 13.1.11. Ferring Pharmaceuticals
- 13.1.12. Glenmark Pharmaceuticals Limited
- 13.1.13. Horizon NJ Health by Horizon Blue Cross Blue Shield of New Jersey
- 13.1.14. KVR Pharmaceuticals
- 13.1.15. Manus Aktteva Biopharma LLP
- 13.1.16. Midas Pharma GmbH
- 13.1.17. NorthStar Rx LLC
- 13.1.18. Pfizer Inc.
- 13.1.19. Ralington Pharma LLP
- 13.1.20. Saintroy Lifescience
- 13.1.21. Sanofi S.A.
- 13.1.22. Sava Healthcare Limited
- 13.1.23. Sun Pharmaceutical Industries Limited
- 13.1.24. Teva Pharmaceutical Industries Ltd.
- 13.1.25. VIVAN Life Sciences Pvt. Limited
- 13.2. Key Product Portfolio
14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
LIST OF FIGURES
- FIGURE 1. DESMOPRESSIN MARKET RESEARCH PROCESS
- FIGURE 2. DESMOPRESSIN MARKET SIZE, 2023 VS 2030
- FIGURE 3. DESMOPRESSIN MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. DESMOPRESSIN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. DESMOPRESSIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. DESMOPRESSIN MARKET DYNAMICS
- FIGURE 7. DESMOPRESSIN MARKET SIZE, BY FORM, 2023 VS 2030 (%)
- FIGURE 8. DESMOPRESSIN MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2023 VS 2030 (%)
- FIGURE 10. DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. DESMOPRESSIN MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
- FIGURE 12. DESMOPRESSIN MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES DESMOPRESSIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES DESMOPRESSIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. DESMOPRESSIN MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. DESMOPRESSIN MARKET SHARE, BY KEY PLAYER, 2023
LIST OF TABLES
- TABLE 1. DESMOPRESSIN MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. DESMOPRESSIN MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL DESMOPRESSIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 6. DESMOPRESSIN MARKET SIZE, BY INJECTABLE SOLUTION, BY REGION, 2018-2030 (USD MILLION)
- TABLE 7. DESMOPRESSIN MARKET SIZE, BY NASAL SPRAY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 8. DESMOPRESSIN MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 10. DESMOPRESSIN MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. DESMOPRESSIN MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 13. DESMOPRESSIN MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 14. DESMOPRESSIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. DESMOPRESSIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. AMERICAS DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 17. AMERICAS DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 18. AMERICAS DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 19. AMERICAS DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 20. ARGENTINA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 21. ARGENTINA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 22. ARGENTINA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 23. BRAZIL DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 24. BRAZIL DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 25. BRAZIL DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 26. CANADA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 27. CANADA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 28. CANADA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 29. MEXICO DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 30. MEXICO DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 31. MEXICO DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 32. UNITED STATES DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 33. UNITED STATES DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 34. UNITED STATES DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 35. UNITED STATES DESMOPRESSIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 36. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 37. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 38. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 39. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 40. AUSTRALIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 41. AUSTRALIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 42. AUSTRALIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 43. CHINA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 44. CHINA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 45. CHINA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 46. INDIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 47. INDIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 48. INDIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 49. INDONESIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 50. INDONESIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 51. INDONESIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 52. JAPAN DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 53. JAPAN DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 54. JAPAN DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 55. MALAYSIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 56. MALAYSIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 57. MALAYSIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 58. PHILIPPINES DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 59. PHILIPPINES DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 60. PHILIPPINES DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 61. SINGAPORE DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 62. SINGAPORE DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 63. SINGAPORE DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 64. SOUTH KOREA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 65. SOUTH KOREA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 66. SOUTH KOREA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 67. TAIWAN DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 68. TAIWAN DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 69. TAIWAN DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 70. THAILAND DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 71. THAILAND DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 72. THAILAND DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 73. VIETNAM DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 74. VIETNAM DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 75. VIETNAM DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 76. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 77. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 78. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 79. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 80. DENMARK DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 81. DENMARK DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 82. DENMARK DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 83. EGYPT DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 84. EGYPT DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 85. EGYPT DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 86. FINLAND DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 87. FINLAND DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 88. FINLAND DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 89. FRANCE DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 90. FRANCE DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 91. FRANCE DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 92. GERMANY DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 93. GERMANY DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 94. GERMANY DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 95. ISRAEL DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 96. ISRAEL DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 97. ISRAEL DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 98. ITALY DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 99. ITALY DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 100. ITALY DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 101. NETHERLANDS DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 102. NETHERLANDS DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 103. NETHERLANDS DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 104. NIGERIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 105. NIGERIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 106. NIGERIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 107. NORWAY DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 108. NORWAY DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 109. NORWAY DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 110. POLAND DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 111. POLAND DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 112. POLAND DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 113. QATAR DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 114. QATAR DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 115. QATAR DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 116. RUSSIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 117. RUSSIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 118. RUSSIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 119. SAUDI ARABIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 120. SAUDI ARABIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 121. SAUDI ARABIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 122. SOUTH AFRICA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 123. SOUTH AFRICA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 124. SOUTH AFRICA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 125. SPAIN DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 126. SPAIN DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 127. SPAIN DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 128. SWEDEN DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 129. SWEDEN DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 130. SWEDEN DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 131. SWITZERLAND DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 132. SWITZERLAND DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 133. SWITZERLAND DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 134. TURKEY DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 135. TURKEY DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 136. TURKEY DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 137. UNITED ARAB EMIRATES DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 138. UNITED ARAB EMIRATES DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 139. UNITED ARAB EMIRATES DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 140. UNITED KINGDOM DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
- TABLE 141. UNITED KINGDOM DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
- TABLE 142. UNITED KINGDOM DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
- TABLE 143. DESMOPRESSIN MARKET, FPNV POSITIONING MATRIX, 2023
- TABLE 144. DESMOPRESSIN MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 145. DESMOPRESSIN MARKET LICENSE & PRICING
